Page last updated: 2024-08-17

carbostyril and Tularemia

carbostyril has been researched along with Tularemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Bentayeb, H; Dayen, C; Douadi, Y; Ducatez, N; Lecuyer, E; Melboucy, S; Suguenot, R1
Escapa-Garrachón, J; Hidalgo, SF; Martín-Serradilla, JI; Prieto de Paula, JM1
Al Dahouk, S; Dierich, MP; Hofer, E; Neubauer, H; Splettstoesser, WD; Tomaso, H; Treu, TM1
Erdogan, S; Finke, EJ; Gedikoglu, S; Grunow, R; Meric, M; Sayan, M; Willke, A1
Audic, S; Biswas, S; Drancourt, M; Elkarkouri, K; Fournous, G; La Scola, B; Li, W; Löfdahl, S; Raoult, D; Robert, C; Rolain, JM; Wahab, T1
Berdal, BP; Hoel, T; Sandvik, T; Scheel, O1
Bubnov, VP; D'iakov, SI; Lebedeva, IK; Moskalenko, VI; Sidorenko, SV1

Other Studies

7 other study(ies) available for carbostyril and Tularemia

ArticleYear
A case of Francisella tularensis meningitis in a 64-year-old man treated with quinolones.
    Infectious diseases now, 2022, Volume: 52, Issue:2

    Topics: Fever; Francisella tularensis; Humans; Male; Meningitis; Middle Aged; Quinolones; Tularemia

2022
Quinolones and oropharyngeal tularemia.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2008, Volume: 116, Issue:12

    Topics: Antibodies, Bacterial; Francisella tularensis; Humans; Pharyngitis; Quinolones; Treatment Outcome; Tularemia

2008
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:4

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Austria; Carbapenems; Cephalosporins; Chloramphenicol; Francisella tularensis; Hares; Humans; Microbial Sensitivity Tests; Quinolones; Rifampin; Tetracycline; Tularemia

2005
Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2008, Volume: 116, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Sedimentation; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Lymphatic Diseases; Male; Middle Aged; Pharyngitis; Quinolones; Risk Factors; Time Factors; Treatment Outcome; Tularemia; Turkey

2008
Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm.
    Genome research, 2008, Volume: 18, Issue:5

    Topics: Chromosome Mapping; Databases, Genetic; DNA, Intergenic; Drug Resistance, Bacterial; Francisella tularensis; Genes, Bacterial; Genome, Bacterial; Genomics; Humans; Microbiology; Molecular Sequence Data; Mutation; Phylogeny; Quinolones; Species Specificity; Tularemia; Virulence Factors

2008
Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1993, Volume: 101, Issue:1

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chloramphenicol; Doxycycline; Francisella tularensis; Gentamicins; Humans; Lagomorpha; Microbial Sensitivity Tests; Quinolones; Rodentia; Scandinavian and Nordic Countries; Tularemia

1993
[The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2000, Volume: 45, Issue:6

    Topics: Aerosols; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoroquinolones; Mice; Particle Size; Quinolones; Research Design; Tularemia

2000